Search

everythinglearnresearchcommunity

for

Search:↓

Late-onset alopecia areata in Taiwanese patients is more common in women, usually starts at age 57, often involves less than 10% hair loss, and may have a minimal link to thyroid issues.

A teenager had both alopecia areata and vitiligo, which are rare to occur together.

Premature graying of hair may suggest health issues and currently lacks effective treatments.

Different types of fibroblasts play various roles in kidney repair and aging, and may affect chronic kidney disease outcomes.

New protein changes may be involved in the immune attack on hair follicles in alopecia areata.

The document concludes that Cutaneous Lupus Erythematosus has different forms, is influenced by genetic and environmental factors, and can be treated with various medications, but more targeted therapies are needed.

The article suggests managing interferon beta therapy side effects in MS with dose adjustments, medications, and patient education.

New treatments for the autoimmune hair loss condition alopecia areata may include JAK inhibitors and other immunomodulators.

The review concludes that innovations in regenerative medicine, tissue engineering, and developmental biology are essential for effective tissue repair and organ transplants.

Alopecia areata severity and treatment response are linked to specific cytokine levels.

New treatments for alopecia areata, like JAK inhibitors and immunomodulators, are promising.

Catalytic antibodies are early indicators and active participants in the development of systemic lupus erythematosus.

A rare endocrine disorder, APS 1, was diagnosed in a 26-year-old man in Bangladesh.

The AIRE gene variant rs2075876 is linked to a higher risk of alopecia areata in males.

AIRE-deficient rats developed severe autoimmune disease similar to APECED, useful for testing treatments.

Vitiligo causes white skin patches and is linked to autoimmune issues.

An 11-year-old child with total hair loss may have a genetic autoimmune disease, and the outlook for hair regrowth is not good.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

Alopecia areata is an autoimmune hair loss condition treated with corticosteroids, and histologic confirmation is the best diagnosis method.

Skin problems are common in Lupus patients and can indicate the disease's severity, requiring specific treatments and lifestyle changes.

The document concludes that understanding how the skin's immune system and inflammation work is complex and requires more research to improve treatments for skin diseases.

The document explains hair and nail biology, common hair loss conditions and treatments, oral and genital skin diseases, and the risks and treatments associated with squamous cell carcinoma.

Alopecia areata involves immune response and gene changes affecting hair loss.

Immune checkpoint inhibitors can cause skin issues but are linked to better cancer outcomes.

Oxidative stress may contribute to hair loss in alopecia areata and antioxidants could potentially help as a treatment.

No treatment alters the natural progression of alopecia areata, and effectiveness varies, with some possibly working better in children.

Accurate diagnosis is key for treating different kinds of hair loss, and immune response variations may affect the condition and treatment results.

Higher DKK-1 levels found in hair loss patients; L-ascorbic acid 2-phosphate, L-threonate, and ginsenoside F2 may help promote hair growth.

Diagnosing alopecia areata is challenging and requires careful examination and various tests to distinguish it from other hair loss types.

New research has found 14 genes linked to the risk of developing alopecia areata, improving understanding and treatment options.